Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Desperation
View:
Post by allibabba on Feb 19, 2022 3:42pm

Desperation

I've been here a long time and have seen many pumpers come and go.  I have a very pessimistic stance on the future of this company since the convertible note financing that killed the company in my opinion.  

I find it very funny that pumpers on this board pumped and pumped and called people names all the way down from 4 dollars when everyone said it had to go up because BMO participated in the bought deal.  Since then revenues have disappeared, there have been lawsuits against the company and they supposedly transitioned to a pharma company with sales "ramping up" for the last 2 years yet revenues have dropped.  

Those same people cheered while the MJ sector cratered because LABS is not in the pot business anymore, it's a pharma play.  All a bunch of nonsense.  The hilarious part is that now it's rumoured that they are buying a small grower (clearly not GMP) to get back into the recreation market to scrounge up some revenues and you guys are happy about this.  It's a terrible idea, it's going to cost the company either cash or more dilution and it's completely reversing course again from their earlier transition to a pharma company.

I am hoping for an increase in share price to run for the hills but I've already written this one off.  The company is desperate, put whatever spin you want on it.  The only hope is a large pharma partnership and they have let too many others catch up at this point.  

GLTA

Comment by Solid1 on Feb 19, 2022 5:37pm
Yes, this bond was wrong, but it could have been worse - the dilution is still limited. I think the new CFO has done a good job and the company is now in a good position with its new products and pharma licences. But yes, if the rumour is true and Labs now wants to enter the leisure market, it won't suppose well. But I think rumours are being spread here deliberately to write off the new ...more  
Comment by alleyesonme on Feb 19, 2022 5:37pm
Fact of the matter....whether someone holds a negative or positive outlook the opinions expressed here have ZERO effect on share price......most investors practice due diligence and don't place trades based on random comments made by strangers on the internet...... just like LP's stopped buying oils from labs and began extracting on their own......... it's time for Labs to stop buying ...more  
Comment by anjz661 on Feb 20, 2022 9:15am
The biggest factor in share price is profitability.  That pretty much speaks for itself.
Comment by alleyesonme on Feb 21, 2022 3:09pm
The biggest factor in share price is investor sentiment...I can list all day unprofitable company's worth billions...company's with little or no revenue have billion dollar valuations based on sentiment and the belief one day they will become profitable....strangely profitability doesn't mean Jack...the future prospect is...
Comment by alleyesonme on Feb 21, 2022 3:22pm
I.E...canopy growth...market cap 3.6 Billion....every dollar of revenue is 1.76 spent...negative 76% profit...profitability...non factor and this is a fact... the evidence is every other company trading and trillions in market values.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities